Low-dose Arsenic induces chemotherapy protection via p53/NF-κB-mediated metabolic regulation
Most chemotherapeutical drugs kill cancer cells chiefly by inducing DNA damage, which unfortunately also causes undesirable injuries to normal tissues, mainly due to p53 activation. We report a novel strategy of normal tissue-protection that involves p53/NF-κB coordinated metabolic regulation. Pretr...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467814/ |